Sabina Janciauskiene Wallmark has completed her PhD at Lund University, Sweden. She is the molecular pulmonology research group leader/professor at the Department of Respiratory Medicine, Hannover Medical School, Germany. Her research group specializes in protease-anti-protease translational research and studying the mechanisms controlling acute and chronic inflammation with particular emphasis on the multiple roles played by a1-antitrypsin in chronic inflammatory diseases, such as chronic obstructive pulmonary disease, cancer, diabetes, inflammatory bowel diseases, skin diseases and liver diseases, among others. We are specifically interested in ?1-antitrypsin protein as an immune-modulatory therapeutic. She is a Scientific Advisory Board member in Alpha1 German patient association and a member of European Reference Network “Rare Liver” and EASL registry “AATD-related liver disease”, Member of The European Alpha-1 Research Collaboration (EARCO) network and a Member of the German Respiratory Society She has over 200 publications that have been cited over 6900 times, and her publication H-index is 46 and has been serving as an editorial board member of reputed Journals, published several book chapters.
molecular pulmonology research
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
